Changes in medicines procurement policies urgently needed to ensure secure supply of essential medicines

19 February 2024

Health Policy Watch: Forum Discusses High Drug Prices in Wealthy Countries and Access to Medicines in Conflicts

12 February 2024

Adrian van den Hoven, chair of the International Generic and […]

Joint statement Association for Accessible Medicines – Medicines for Europe ahead of 5th EU-U.S. Trade and Technology Council Ministerial meeting

26 January 2024

Court decision on Supplementary Protection Certificate (SPC) manufacturing waiver risks undermining its use

18 January 2024

Medicines for Europe and European Business Association propose priority steps to continue the EU integration of the Ukrainе’s pharmaceutical industry

15 January 2024

The European Union cannot jeopardise patient access to generic medicines through the Urban Wastewater Treatment Directive

8 January 2024

Biosimilar medicines critical for future medicines access and sustainability but more biologic competition is needed in the EU

13 December 2023

(Original in SK) How low pricing of generic and biosimilar drugs relates to their shortage

27 November 2023

OPEN LETTER: Members of the European Parliament and EU 27 Ministers of Health on the revision of the pharmaceutical legislation

8 November 2023

New IQVIA report points to window of opportunity for the EU to foster future-proof biosimilar competition

26 October 2023